The CEO of ModeX Therapeutics discusses MDX2003, a groundbreaking tetraspecific therapy that promises enhanced efficacy and ...
Immune cells called B cells make antibodies that fight off invading bacteria, viruses and other foreign substances. During ...
Certain antibodies employ unusual tactics to keep germs from attaching to cells in our bodies. Their defensive strategies ...
Immune cells called B cells make antibodies that fight off invading bacteria, viruses and other foreign substances. During ...
Multiple myeloma, a cancer of the bone marrow, remains difficult to treat despite modern CAR T cell therapies. In recent ...
3don MSN
Antibodies' decoy tactics for outmaneuvering pathogens could inspire next-generation treatments
Pathogens can create sticky situations. When microbes invade the body to cause an infection, often one of their first lines ...
The study, "A transcriptionally distinct subset of influenza-specific effector memory B cells predicts long-lived antibody responses to vaccination in humans,” was published in Immunity. “Our study ...
French biotech Innate Pharma is recruiting natural-born killers to target B cell non-Hodgkin lymphoma (B-NHL). The company’s tetraspecific antibody controlled tumors and improved survival in mice and ...
Our immune system works to fight infections immediately, but also maintain long-term immunity. Two waves of protection help neutralize and eliminate disease, including the innate and adaptive immune ...
Scientists have found that antibodies stop UTI-causing E. coli by jamming or mimicking cell receptors, preventing bacterial ...
Single B-cell technologies have emerged as powerful screening tools to accelerate antibody discovery, offering R&D teams the potential to interrogate millions of individual antibody-secreting cells to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback